An elevated FIB-4 score predicts liver cancer development: a longitudinal analysis from 29,999 NAFLD patients: Reply to: "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis- 2021 update".
暂无分享，去创建一个
[1] M. Friedrich-Rust,et al. Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update. , 2021, Journal of hepatology.
[2] P. Fariselli,et al. Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease. , 2021, Journal of hepatology.
[3] V. de Lédinghen,et al. Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis , 2021, Liver international : official journal of the International Association for the Study of the Liver.
[4] J. Lazarus,et al. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. , 2018, Journal of hepatology.
[5] H. Lee,et al. Association between non-alcoholic fatty liver disease and cancer incidence rate. , 2017, Journal of hepatology.
[6] J. Dufour,et al. Hepatocellular carcinoma and lifestyles. , 2016, Journal of hepatology.
[7] J. Montaner,et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.